Risperdal Lawsuit Ends in Win for Plaintiff, But No Damages

Jury Finds Risperdal Caused Plaintiff’s Gynecomastia, But Awards No Financial Damages On Friday, March 20th, the jury for the latest Risperdal personal injury lawsuit ruled that Johnson & Johnson failed to warn doctors and patients of the risks of using Risperdal for off-label prescriptions, which led to the plaintiff’s gynecomastia; however, … [Read more...]

Opening Arguments Begin in Risperdal MDL Injury Case

Risperdal MDL in Philadelphia Begins Opening Arguments On Friday, January 23rd, the Risperdal MDL (multidistrict litigation) alleging long-lasting personal injury caused by the drug Risperdal, when used for off-label purposes, began in Philadelphia. Opening arguments debated the specific personal injury claim that using Risperdal in young boys … [Read more...]

$70 Million Verdict Against J&J in Risperdal Trial

Largest Verdict Thus Far Against Jansen for $70 Million in Risperdal Trial According to Reuters, Janssen Pharmaceuticals, a unit of Johnson & Johnson, was hit with a $70 million verdict in a Risperdal trial last week, marking the largest verdict against Janssen thus far in this ongoing litigation. The award was handed down in the case of a 15 … [Read more...]

J&J Loses First Risperdal Gynecomastia Trial

Plaintiff Awarded $2.5 Million in Damages for Risperdal Gynecomastia Side-Effects In the first Risperdal gynecomastia personal injury trial for the multidistrict litigation, a Philadelphia jury has decided in favor of the plaintiff, and awarded the victim of Risperdal’s side effects $2.5 million. Risperdal was approved in 1993, launched in 1994, … [Read more...]

BestLawyers.comAVBetter Business Bureau